Crispr Therapeutics AG (CRSP)
NASDAQ · Healthcare
Crispr Therapeutics AG Total Assets 2015–2025
Crispr Therapeutics AG annual total assets history from 2015 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Crispr Therapeutics AG total assets as of December 31, 2025: 2.27B, a 1.04% increase year-over-year.
- Crispr Therapeutics AG total assets for 2025 were 2.27B, a 1.04% increase from 2024.
- Crispr Therapeutics AG total assets for 2024 were 2.24B, a 0.56% increase from 2023.
- Crispr Therapeutics AG total assets for 2023 were 2.23B, a 0.60% decrease from 2022.
- Crispr Therapeutics AG total assets for 2022 were 2.24B.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Crispr Therapeutics AG Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $2,265 |
| 2024 | $2,242 |
| 2023 | $2,230 |
| 2022 | $2,243 |
| 2021 | $2,752 |
| 2020 | $1,828 |
| 2019 | $1,067 |
| 2018 | $489 |
| 2017 | $271 |
| 2016 | $345 |
| 2015 | $159 |
Crispr Therapeutics AG Total Assets — FAQ
Crispr Therapeutics AG (CRSP) total assets over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRSP's total assets history?
The chart and table above show Crispr Therapeutics AG's total assets by year and by quarter, including the growth rate.